Evidence map›Paper›PMID 38497025›Full record

ArticleACS omega2024

B(C

Qian Xiao, Sixian Fang, Jiaming Ao, Xiaoya Zhao, Cai Huang, Yuhua Liu, Yichu Nie, Akihiro Ishiwata, Katsunori Tanaka, Wenbin Deng and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. ZnIMolecules (Basel, Switzerland) · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Qian XiaoSchool of Pharmaceutical Sciences (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen 518107, China.
Sixian FangSchool of Pharmaceutical Sciences (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen 518107, China.
Jiaming AoSchool of Pharmaceutical Sciences (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen 518107, China.
Xiaoya ZhaoSchool of Pharmaceutical Sciences (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen 518107, China.
Cai HuangSchool of Pharmaceutical Sciences (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen 518107, China.
Yuhua LiuSchool of Physics and Electronic Engineering, Guangzhou University, Guangzhou 510006, China.
Yichu NieTranslational Medicine Research Institute, First People's Hospital of Foshan, Foshan 528000, China.
Akihiro IshiwataRIKEN Cluster for Pioneering Research, Wako, Saitama 3510198, Japan.ORCID https://orcid.org/0000-0002-5542-2214
Katsunori TanakaRIKEN Cluster for Pioneering Research, Wako, Saitama 3510198, Japan.ORCID https://orcid.org/0000-0001-6932-4802
Wenbin DengSchool of Pharmaceutical Sciences (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen 518107, China.ORCID https://orcid.org/0000-0002-8897-4891
Feiqing DingSchool of Pharmaceutical Sciences (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen 518107, China.ORCID https://orcid.org/0000-0002-0211-7101

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Compared with stereoselective glycosylation methods mainly addressed on the preparation of pyranose glycosides, the furanosylation has been more limited, especially for the 1,2-

Identifiers

PMID38497025
PMCPMC10938590

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.